Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/87659
Title: | Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class. | |
Authors: | ||
Mesh: | ||
Issue Date: | 8-Jul-2021 | |
Citation: | Neurologia (Engl Ed).2021;(36)8:638-640 | |
PMID: | 34246579 | |
URI: | https://hdl.handle.net/20.500.12530/87659 | |
Rights: | OpenAccess | |
Appears in Collections: | Hospitales > H. U. Clínico San Carlos > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos | |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Failure of monoclonal antibodies against CGRP.pdf | 606.44 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License